亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

北京凱森萊醫藥科技有限公司  

iptg,og,pnpg,onpg,葡萄糖醛酸,酶底物

搜索
新聞中心
  • 暫無新聞
聯系方式
  • 聯系人:陶彪
  • 電話:010-61274189
  • 郵件:chemsynlab@163.com
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 歡迎光臨
公司介紹
北京凱森萊醫藥科技有限公司是一家專業從事糖類藥物以及糖苷類酶底物等精細化學品的技術開發,生產和銷售的企業. 酶底物的研發和生產是該公司的一大特色,其質量和成本達到國際領先水平. 公司常年為歐洲和印度糖產品的分銷商提供常規糖中間體和糖苷酶底物等等。
目前公司開發的酶底物主要是硫苷類和酚苷類兩大類,包括D-葡萄糖苷酶底物, D-半乳糖苷酶底物,D-木糖,D-甘露糖苷酶底物和2-氨基-D-葡萄糖苷酶底物等等.
Beijing Chemsynlab Pharmaceutical Science & Technology Co. Ltd., focuses on R&D of pharmaceuticals and intermediates, especially on carbohydrate chemistry since founded in 2004 by Li Dr.,  Li Zhang. and Guo Dr.. They all have rich experimence on the synthesis of oligosaccharides and its derivatives. Beijing Chemsynlab offers the synthesis of carbohydrate compounds from milligram to kilogram scale. Beijing Chemsynlab has developed and diversified into many areas of carbohydrate research and synthesis by now. Many products involving carbohydrate building blocks can be supplied by us, such as active... [詳細介紹]
推薦產品
最新供應
品牌展示
暫無記錄
©2025 北京凱森萊醫藥科技有限公司 版權所有   技術支持:化工網   訪問量:5613  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |